Comparing Machine Learning Models for Aromatase (P450 19A1)
- PMID: 33207874
- PMCID: PMC8194505
- DOI: 10.1021/acs.est.0c05771
Comparing Machine Learning Models for Aromatase (P450 19A1)
Abstract
Aromatase, or cytochrome P450 19A1, catalyzes the aromatization of androgens to estrogens within the body. Changes in the activity of this enzyme can produce hormonal imbalances that can be detrimental to sexual and skeletal development. Inhibition of this enzyme can occur with drugs and natural products as well as environmental chemicals. Therefore, predicting potential endocrine disruption via exogenous chemicals requires that aromatase inhibition be considered in addition to androgen and estrogen pathway interference. Bayesian machine learning methods can be used for prospective prediction from the molecular structure without the need for experimental data. Herein, the generation and evaluation of multiple machine learning models utilizing different sources of aromatase inhibition data are described. These models are applied to two test sets for external validation with molecules relevant to drug discovery from the public domain. In addition, the performance of multiple machine learning algorithms was evaluated by comparing internal five-fold cross-validation statistics of the training data. These methods to predict aromatase inhibition from molecular structure, when used in concert with estrogen and androgen machine learning models, allow for a more holistic assessment of endocrine-disrupting potential of chemicals with limited empirical data and enable the reduction of the use of hazardous substances.
Conflict of interest statement
Competing interests:
S.E. is owner, K.M.Z., D.H.F., and T.R.L., are employees of Collaborations Pharmaceuticals Inc. All other authors are SC Johnson and Son, Inc. employees.
Figures


References
-
- EPA, U. EPA Endocrine Disruptor Screening Program Tier 1 Battery of Assays. https://www.epa.gov/endocrine-disruption/endocrine-disruptor-screening-p...
-
- Judson RS; Magpantay FM; Chickarmane V; Haskell C; Tania N; Taylor J; Xia M; Huang R; Rotroff DM; Filer DL; Houck KA; Martin MT; Sipes N; Richard AM; Mansouri K; Setzer RW; Knudsen TB; Crofton KM; Thomas RS, Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor. Toxicol Sci 2015, 148 (1), 137–54. - PMC - PubMed
-
- Browne P; Judson RS; Casey WM; Kleinstreuer NC; Thomas RS, Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model. Environ Sci Technol 2015, 49 (14), 8804–14. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources